ESC Premium Access

Association of adipose tissue insulin resistance and serum free fatty acid levels with the incidence of type 2 diabetes: a retrospective cohort study

Topic: Metabolic Syndrome, Insulin, Insulin Resistance

Congress Session

About the speaker

Doctor Nobuo Sasaki

Hiroshima Atomic Bomb Casualty Council, Hiroshima (Japan)
0 follower

224 more presentations in this session

High risk characteristics in patients with hypertrophic cardiomiyopathy for predicting cardiovascular events

Speaker: Doctor B. Keskin (Istanbul, TR)

Thumbnail

Cardiac biomarkers as prognosticators among SARS-CoV-19 patients in a tertiary hospital in Philippines

Speaker: Doctor R. Ong (Makati, PH)

Thumbnail

Prevalence of atherosclerosis risk factors in Egyptian patients with acute coronary syndromes; final data of the nationwide cross-sectional CardioRisk project

Speaker: Doctor A. Bendary (Benha, EG)

Thumbnail

SF-12 Physical and Mental Health Scales predict cardiovascular events after hospitalization

Speaker: Mr R. Gascuena (Leganes, ES)

Thumbnail

Comparison of traditional versus artificial intelligence based coronary artery disease risk prediction scores in young patients with acute coronary syndrome

Speaker: Doctor S. Vohra (Lucknow, IN)

Thumbnail

Access the full session

Risk Factors and Prevention ePosters

Speakers: Doctor N. Sasaki, Doctor B. Keskin, Doctor R. Ong, Doctor A. Bendary, Mr R. Gascuena...
Thumbnail

About the event

Image

ESC Congress 2021 - The Digital Experience

27 August - 30 August 2021

Sessions Presentations

Related content

ESC Premium Access

Early Rhythm-Control Therapy in Patients with Atrial Fibrillation: A nationwide cohort study

30 August 2021

ESC Premium Access

Activation of the Apelin Receptor by LIT01-196 as a New Strategy for Prevention of Heart Failure After Myocardial Infarction

27 August 2021

ESC Premium Access

REDUCE-IT PRIOR MI: Reduction in Ischemic Events, Including Cardiovascular Mortality, with Icosapent Ethyl in Patients with Prior Myocardial Infarction

27 August 2021

This platform is supported by

logo Novo Nordisk